ARCHIVES

DCT Advisors Approve Grants Program For Trials Of BRMs

This article is from The Cancer Letter archive.

Vol. 21 No. 10 | March 10, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

ORI Misconduct Findings Announced In Two Cases

July 12, 1996

Provenge Met Criteria For Approval, Sponsor Says

May 1, 2009

Director’s Advisory Committee to Make Advice “Kosher”

March 7, 1997

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

Illinois Cancer Center Closes Following Veto of State Funds; Was First Consortium Center

December 11, 1992